C
Cornelius Kortsik
Researcher at University of Freiburg
Publications - 29
Citations - 811
Cornelius Kortsik is an academic researcher from University of Freiburg. The author has contributed to research in topics: Lung cancer & Sputum. The author has an hindex of 11, co-authored 29 publications receiving 750 citations.
Papers
More filters
Journal ArticleDOI
T Cells and Cytokines in Bronchoalveolar Lavage Fluid after Segmental Allergen Provocation in Atopic Asthma
TL;DR: The correlation between IL-5 levels, eosinophil numbers, and activated T cells supports a role for T-cell-derived IL-2R+/CD4+ T cells in causing tissue eOSinophilia in allergic asthma.
Journal ArticleDOI
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.
Kenneth J. O'Byrne,Ulrich Gatzemeier,Igor Bondarenko,Carlos H. Barrios,Corinna Eschbach,Uwe M. Martens,Yevhen Hotko,Cornelius Kortsik,Luis Paz-Ares,José Rodrigues Pereira,Joachim von Pawel,Rodryg Ramlau,Jae Kyung Roh,Chih Teng Yu,Christopher Stroh,Ilhan Celik,Armin Schueler,Robert Pirker +17 more
TL;DR: The FLEX study as discussed by the authors showed that the addition of cetuximab to cisplatin and vinorelbine significantly improved overall survival in the first-line treatment of EGFRexpressing, advanced non-small-cell lung cancer (NSCLC).
Journal ArticleDOI
The Efficacy and Safety of BI 2536, a Novel Plk-1 Inhibitor, in Patients with Stage IIIB/IV Non-small Cell Lung Cancer Who Had Relapsed after, or Failed, Chemotherapy Results from an Open-Label, Randomized Phase II Clinical Trial
Martin Sebastian,Martin Reck,Cornelius F. Waller,Cornelius Kortsik,N. Frickhofen,Martin Schuler,Holger Fritsch,Birgit Gaschler-Markefski,Gertraud Hanft,Gerd Munzert,Joachim von Pawel +10 more
TL;DR: BI 2536 monotherapy has modest efficacy and favorable safety in relapsed non-small cell lung cancer and the findings support the further development of polo-like kinase-1 inhibitors within this indication.
Journal ArticleDOI
Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas.
TL;DR: Sputum specimens were most valuable in the detection of early and peripheral carcinomas, whereas brushing was superior in finding more advanced and centrally located malignancies.
Journal ArticleDOI
Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
Marlene Hechtner,Marlene Hechtner,Martin Eichler,Beatrice Wehler,Roland Buhl,Martin Sebastian,Jan Stratmann,Heinz Schmidberger,Bernhard Gohrbandt,Jessica Peuser,Cornelius Kortsik,Ursula Nestle,Sebastian Wiesemann,Hubert Wirtz,Thomas Wehler,Robert Bals,Maria Blettner,Susanne Singer +17 more
TL;DR: Lung cancer survivors experience both functional restrictions and symptoms that persist long term after active treatment ends, substantiates the importance of providing long‐term supportive care.